Requip and Glipizide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Requip (ropinirole hydrochloride) and Glipizide (glipizide). Common drug interactions include diarrhoea among females and fall among males.
The phase IV clinical study analyzes what interactions people have when they take Requip and Glipizide. It is created by eHealthMe based on reports of 254 people who take the same drugs from the FDA, and is updated regularly.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
What is Glipizide?
Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
254 people who take Requip and Glipizide together, and have interactions are studied.
What are the common drug interactions of Requip and Glipizide, by gender? *
What are the common drug interactions of Requip and Glipizide, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Requip and Glipizide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Requip and Glipizide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Glipizide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Glipizide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
- Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ropinirole hydrochloride and glipizide (the active ingredients of Requip and Glipizide, respectively), and Requip and Glipizide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mometasone Furoate cause Abdominal Pain Upper? - 2 seconds ago
- Could Ubiquinol cause Hair Loss? - 3 seconds ago
- Drug interactions of Jakafi and Diphen - 9 seconds ago
- Could Alphagan cause Tinnitus? - 11 seconds ago
- Chest Pain Aggravated and Lump In The Abdomen - 23 seconds ago
- Could Gentamicin cause Foot Amputation? - 23 seconds ago
- Drug interactions of Lidocaine And Prilocaine and Tamsulosin - 29 seconds ago
- Could Exforge cause Swallowing Difficulty? - 29 seconds ago
- Could Pravastatin Sodium cause Dental Fistula? - 33 seconds ago
- Could Percocet cause Blood Urea Nitrogen/Creatinine Ratio Increased? - 34 seconds ago